Orzaks Pharma Begins Trading on Borsa Istanbul After Successful IPO

Orzaks İlaç ve Kimya Sanayi Ticaret AŞ completed its public offering and started trading on Borsa Istanbul under the ticker ORZAX. A gong ceremony was held with Borsa Istanbul General Manager Korkmaz Ergun, Orzaks CEO Yunus Emre Alimoğlu, and Info Yatırım Deputy General Manager Hüseyin Güler speaking. Ergun said the listing will allow Orzaks to “use the proceeds from the offering to implement investments, increase production capacity and continue its growth journey with confidence.”

Alimoğlu highlighted the company’s 22‑year history, its market‑leader status in Turkey since 2019, and its mission to develop products that improve preventive and protective health. He described the IPO as opening “a new era” and reiterated the plan to expand “from local to global,” adding that Orzaks will deepen its portfolio in dermocosmetics, sports nutrition, biotechnological raw‑material stages and pharmaceuticals. Güler noted that roughly one million investors took part in the offering, seeing it as a strong signal of confidence in the company and in Turkey’s capital markets.